UBS O'Connor’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.67M | Buy |
53,343
+8,147
| +18% | +$256K | 0.09% | 155 |
|
|
2025
Q1 | $1.34M | Sell |
45,196
-78
| -0.2% | -$2.31K | 0.04% | 149 |
|
|
2024
Q4 | $1.34M | Buy |
45,274
+10,162
| +29% | +$300K | 0.04% | 201 |
|
|
2024
Q3 | $1.09M | Sell |
35,112
-4,902
| -12% | -$153K | 0.03% | 262 |
|
|
2024
Q2 | $1.36M | Buy |
40,014
+11,090
| +38% | +$376K | 0.04% | 250 |
|
|
2024
Q1 | $1.88M | Buy |
28,924
+1,283
| +5% | +$83.4K | 0.05% | 181 |
|
|
2023
Q4 | $1.89M | Sell |
27,641
-11,704
| -30% | -$800K | 0.06% | 178 |
|
|
2023
Q3 | $2.04M | Sell |
39,345
-1,000
| -2% | -$51.9K | 0.04% | 238 |
|
|
2023
Q2 | $2.42M | Sell |
40,345
-7,520
| -16% | -$451K | 0.05% | 238 |
|
|
2023
Q1 | $2.37M | Buy |
+47,865
| New | +$2.37M | 0.06% | 283 |
|
|
2022
Q4 | – | Sell |
-34,697
| Closed | -$1.63M | – | 150 |
|
|
2022
Q3 | $1.63M | Sell |
34,697
-22,800
| -40% | -$1.07M | 0.02% | 667 |
|
|
2022
Q2 | $2.15M | Buy |
+57,497
| New | +$2.15M | 0.02% | 625 |
|